Literature DB >> 9499259

Long-term renal function in patients with irradiated bilateral Wilms tumor. National Wilms' Tumor Study Group.

G R Smith1, P R Thomas, M Ritchey, P Norkool.   

Abstract

The treatment of bilateral Wilms tumor (BWT) involves a multidisciplinary approach including surgery, chemotherapy, and radiation therapy. The long-term renal function in patients receiving all three treatment modalities has not been evaluated. Long-term renal function was evaluated in 81 children with synchronous BWT who received radiation therapy as part of their treatment. Renal function was assessed by measuring blood urea nitrogen (BUN) and serum creatinine (Cr). The normal range for the BUN was defined as 10-24 mg/dl, and the Cr was considered normal at levels of <1.5 mg/dl. Moderate elevations were defined as a BUN of 25-50 mg/dl and/or a Cr of 1.6-2.5 mg/dl and marked elevations as a BUN of >50 mg/dl and/or a Cr of >2.5 mg/dl. BUN and Cr levels were measured prior to treatment and at the following intervals: 6 months after treatment, 1 year after treatment, 2 years after treatment, and at last follow-up. Any elevation during the posttreatment follow-up period was considered abnormal. A total of 28 children (34.6%) had elevated BUN and/or Cr levels, and 18 had moderate and 10 had marked renal insufficiency. No dose-response relationship was established when comparing the radiation doses of those with elevated values to those with normal values. The renal complication rate was moderate, and other factors including surgery, extent and nature of chemotherapy, and recurrent tumor must also be taken into account. The elevations present in several children could be attributed to tumor recurrence and in one case to gentamicin toxicity. The management of children with BWT should consider all of these risks, and attempts to preserve renal parenchyma are warranted.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499259     DOI: 10.1097/00000421-199802000-00013

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  10 in total

Review 1.  Genitourinary long-term outcomes for childhood cancer survivors.

Authors:  Margarett Shnorhavorian; Debra L Friedman; Martin A Koyle
Journal:  Curr Urol Rep       Date:  2009-03       Impact factor: 3.092

Review 2.  Renal late effects in patients treated for cancer in childhood: a report from the Children's Oncology Group.

Authors:  Deborah P Jones; Sheri L Spunt; Daniel Green; James E Springate
Journal:  Pediatr Blood Cancer       Date:  2008-12       Impact factor: 3.167

Review 3.  Wilms tumor.

Authors:  Andrew M Davidoff
Journal:  Adv Pediatr       Date:  2012

Review 4.  Management of bilateral Wilms tumours.

Authors:  Alastair J W Millar; Sharon Cox; Alan Davidson
Journal:  Pediatr Surg Int       Date:  2017-01-04       Impact factor: 1.827

Review 5.  Management of bilateral Wilms tumours.

Authors:  Alastair J W Millar; Sharon Cox; Alan Davidson
Journal:  Pediatr Surg Int       Date:  2017-05-17       Impact factor: 1.827

Review 6.  Risk-based health monitoring of childhood cancer survivors: a report from the Children's Oncology Group.

Authors:  Susan B Nunez; Daniel A Mulrooney; Caroline Laverdiere; Melissa M Hudson
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

Review 7.  Wilms' tumor.

Authors:  Andrew M Davidoff
Journal:  Curr Opin Pediatr       Date:  2009-06       Impact factor: 2.856

8.  Nephron sparing surgery for unilateral non-syndromic wilms tumor.

Authors:  R B Nerli; V C Pujar; M B Hiremath; S M Jali; S S Joshi; S C Hiremath; A K Guntaka
Journal:  Indian J Surg Oncol       Date:  2014-01-22

9.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11

10.  Comprehensive analysis of long non‑coding RNA using an associated competitive endogenous RNA network in Wilms tumor.

Authors:  Zhichao Wang; Huiyan Cheng; Lingli Qi; Dayun Sui
Journal:  Mol Med Rep       Date:  2020-05-05       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.